BSE Live
Feb 01, 16:01Prev. Close
342.75
Open Price
341.50
Bid Price (Qty.)
340.90 (2)
Offer Price (Qty.)
360.95 (1)
NSE Live
Feb 01, 15:59Prev. Close
342.10
Open Price
343.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Medicamen Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 9.45 | 13.30 | 15.00 | 14.91 | 12.49 | |
| Net CashFlow From Operating Activities | -2.63 | -0.25 | -3.50 | 4.81 | 13.29 | |
| Net Cash Used In Investing Activities | -1.72 | -8.71 | -7.54 | -8.47 | -18.12 | |
| Net Cash Used From Financing Activities | -6.68 | 3.14 | 27.67 | 4.39 | 5.68 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -11.04 | -5.82 | 16.63 | 0.73 | 0.85 | |
| Cash And Cash Equivalents Begin of Year | 14.62 | 20.44 | 3.81 | 3.08 | 2.23 | |
| Cash And Cash Equivalents End Of Year | 3.58 | 14.62 | 20.44 | 3.81 | 3.08 |
26.11.2025
Medicamen Bio Consolidated September 2025 Net Sales at Rs 47.17 crore, up 5.42% Y-o-Y
24.11.2025
Medicamen Bio Standalone September 2025 Net Sales at Rs 42.23 crore, down 1.44% Y-o-Y
09.09.2025
Medicamen Bio Standalone June 2025 Net Sales at Rs 38.45 crore, down 7.31% Y-o-Y
11.06.2025
Medicamen Bio Standalone March 2025 Net Sales at Rs 26.00 crore, down 42.24% Y-o-Y
26.11.2025
Medicamen Bio Consolidated September 2025 Net Sales at Rs 47.17 crore, up 5.42% Y-o-Y
24.11.2025
Medicamen Bio Standalone September 2025 Net Sales at Rs 42.23 crore, down 1.44% Y-o-Y
09.09.2025
Medicamen Bio Standalone June 2025 Net Sales at Rs 38.45 crore, down 7.31% Y-o-Y
11.06.2025
Medicamen Bio Standalone March 2025 Net Sales at Rs 26.00 crore, down 42.24% Y-o-Y